• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性胰腺癌与定向筛查的未来。

Familial Pancreatic Cancer and the Future of Directed Screening.

机构信息

Samuel F. Bronfman Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Gut Liver. 2017 Nov 15;11(6):761-770. doi: 10.5009/gnl16414.

DOI:10.5009/gnl16414
PMID:28609837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5669591/
Abstract

Pancreatic cancer (PC) is the third most common cause of cancer-related death in the United States and the 12th most common worldwide. Mortality is high, largely due to late stage of presentation and suboptimal treatment regimens. Approximately 10% of PC cases have a familial basis. The major genetic defect has yet to be identified but may be inherited by an autosomal dominant pattern with reduced penetrance. Several known hereditary syndromes or genes are associated with an increased risk of developing PC and account for approximately 2% of PCs. These syndromes include the hereditary breast-ovarian cancer syndrome, Peutz-Jeghers syndrome, familial atypical multiple mole melanoma, Lynch syndrome, familial polyposis, ataxia-telangiectasia, and hereditary pancreatitis. Appropriate screening using methods such as biomarkers or imaging, with endoscopic ultrasound and magnetic resonance imaging, may assist in the early detection of neoplastic lesions in the high-risk population. If these lesions are detected and treated before the development of invasive carcinoma, PC disease morbidity and mortality may be improved. This review will focus on familial PC and other hereditary syndromes implicated in the increased risk of PC; it will also highlight current screening methods and the future of new screening modalities.

摘要

胰腺癌(PC)是美国癌症相关死亡的第三大常见原因,也是全球第 12 大常见原因。死亡率很高,主要是由于晚期表现和治疗方案不理想。大约 10%的 PC 病例有家族基础。主要的遗传缺陷尚未确定,但可能以常染色体显性遗传模式遗传,外显率降低。一些已知的遗传性综合征或基因与 PC 发病风险增加有关,约占 PC 的 2%。这些综合征包括遗传性乳腺癌-卵巢癌综合征、Peutz-Jeghers 综合征、家族性非典型多发性痣黑素瘤、林奇综合征、家族性息肉病、共济失调-毛细血管扩张症和遗传性胰腺炎。使用生物标志物或影像学等方法进行适当的筛查,如内镜超声和磁共振成像,可能有助于高危人群中肿瘤病变的早期发现。如果在侵袭性癌发生之前发现并治疗这些病变,可能会改善 PC 的发病和死亡率。这篇综述将重点介绍家族性 PC 及其他与 PC 风险增加相关的遗传性综合征;还将突出当前的筛查方法和新筛查方式的未来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce06/5669591/93b95feb7234/gnl-11-761f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce06/5669591/93b95feb7234/gnl-11-761f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce06/5669591/93b95feb7234/gnl-11-761f1.jpg

相似文献

1
Familial Pancreatic Cancer and the Future of Directed Screening.家族性胰腺癌与定向筛查的未来。
Gut Liver. 2017 Nov 15;11(6):761-770. doi: 10.5009/gnl16414.
2
Familial pancreatic carcinoma in Jews.犹太人中的家族性胰腺癌
Fam Cancer. 2004;3(3-4):233-40. doi: 10.1007/s10689-004-9549-8.
3
[Hereditary pancreatic cancer].[遗传性胰腺癌]
Chirurg. 2008 Nov;79(11):1029-37. doi: 10.1007/s00104-008-1559-x.
4
Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?家族性胰腺癌高危患者的筛查:哪些是有益的?
Surg Clin North Am. 2018 Feb;98(1):25-35. doi: 10.1016/j.suc.2017.09.003.
5
Diagnosis and Management of Hereditary Pancreatic Cancer.遗传性胰腺癌的诊断与管理
Recent Results Cancer Res. 2016;205:61-83. doi: 10.1007/978-3-319-29998-3_5.
6
[Hereditary gastric and pancreatic cancer predisposition syndromes].[遗传性胃癌和胰腺癌易感性综合征]
Gastroenterol Hepatol. 2016 Aug-Sep;39(7):481-93. doi: 10.1016/j.gastrohep.2015.11.009. Epub 2016 Feb 23.
7
Familial pancreatic cancer: Concept, management and issues.家族性胰腺癌:概念、管理与问题
World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935.
8
Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection.胰腺导管腺癌:危险因素、筛查与早期检测
World J Gastroenterol. 2014 Aug 28;20(32):11182-98. doi: 10.3748/wjg.v20.i32.11182.
9
Pancreatic cancer screening in high-risk individuals with germline genetic mutations.遗传性基因突变高危人群的胰腺癌筛查。
Gastrointest Endosc. 2018 Jun;87(6):1443-1450. doi: 10.1016/j.gie.2017.12.019. Epub 2018 Jan 5.
10
Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.家族性胰腺癌与遗传性综合征:高危个体的筛查策略。
J Gastroenterol. 2011 Nov;46(11):1249-59. doi: 10.1007/s00535-011-0457-z. Epub 2011 Aug 17.

引用本文的文献

1
Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran.伊朗戈勒斯坦队列研究 15 年随访期间胰腺癌的发病率和危险因素。
PLoS One. 2024 Jun 7;19(6):e0300736. doi: 10.1371/journal.pone.0300736. eCollection 2024.
2
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in .携带种系致病变体的个体中的胰腺癌监测
Cancers (Basel). 2023 Mar 9;15(6):1690. doi: 10.3390/cancers15061690.
3
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.

本文引用的文献

1
MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions.胰腺导管腺癌及其前驱病变中的微小RNA
World J Gastrointest Oncol. 2016 Jan 15;8(1):18-29. doi: 10.4251/wjgo.v8.i1.18.
2
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.巴尔的摩胰腺肿瘤前体病变共识会议的修订分类系统及建议
Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.
3
New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
意大利胰腺癌患者非选择队列中51个癌症易感基因种系致病变异的临床意义
Cancers (Basel). 2022 Sep 13;14(18):4447. doi: 10.3390/cancers14184447.
4
ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway.锌指蛋白 488 通过 Akt/mTOR 通路促进胰腺癌细胞的侵袭和迁移。
Comput Math Methods Med. 2022 Jan 24;2022:4622877. doi: 10.1155/2022/4622877. eCollection 2022.
5
BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives.胃肠道癌症中的BRCA:当前治疗方法与未来展望
Cancers (Basel). 2020 Nov 12;12(11):3346. doi: 10.3390/cancers12113346.
6
Gene Signature and Identification of Clinical Trait-Related m A Regulators in Pancreatic Cancer.胰腺癌中基因特征及临床特征相关m⁶A调节剂的鉴定
Front Genet. 2020 Jul 10;11:522. doi: 10.3389/fgene.2020.00522. eCollection 2020.
7
UEG Week 2019 Oral Presentations.2019年欧洲胃肠内镜学会年会口头报告
United European Gastroenterol J. 2019 Oct;7(8_suppl):10-188. doi: 10.1177/2050640619854670.
8
Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk.医疗保健提供者对照顾有遗传性胰腺癌风险个体的看法。
J Cancer Educ. 2020 Feb;35(1):194-203. doi: 10.1007/s13187-019-01623-1.
9
Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.遗传性胰腺癌综合征和家族性胰腺癌患者的基因组特征和临床管理。
Int J Mol Sci. 2019 Jan 29;20(3):561. doi: 10.3390/ijms20030561.
10
Familial Pancreatic Ductal Adenocarcinoma.家族性胰腺导管腺癌。
Am J Pathol. 2019 Jan;189(1):36-43. doi: 10.1016/j.ajpath.2018.06.026.
胰腺癌的新型DNA甲基化标志物:发现、组织验证及胰液中的初步检测
Clin Cancer Res. 2015 Oct 1;21(19):4473-81. doi: 10.1158/1078-0432.CCR-14-2469. Epub 2015 May 28.
4
A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.EUS 和 MRI 用于高危人群胰腺癌筛查的多中心前瞻性盲法比较分析。
Gut. 2016 Sep;65(9):1505-13. doi: 10.1136/gutjnl-2014-308008. Epub 2015 May 18.
5
Early detection of sporadic pancreatic cancer: summative review.散发性胰腺癌的早期检测:综述
Pancreas. 2015 Jul;44(5):693-712. doi: 10.1097/MPA.0000000000000368.
6
KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.在内镜超声检查时,从患瘤风险高的患者十二指肠收集的胰液中的KRAS和鸟嘌呤核苷酸结合蛋白突变
Clin Gastroenterol Hepatol. 2015 May;13(5):963-9.e4. doi: 10.1016/j.cgh.2014.11.028. Epub 2014 Dec 4.
7
Diabetes, pancreatic cancer, and metformin therapy.糖尿病、胰腺癌和二甲双胍治疗。
Front Physiol. 2014 Nov 7;5:426. doi: 10.3389/fphys.2014.00426. eCollection 2014.
8
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
9
Investigational biomarkers for pancreatic adenocarcinoma: where do we stand?胰腺癌的研究性生物标志物:我们目前的进展如何?
South Med J. 2014 Apr;107(4):256-63. doi: 10.1097/SMJ.0000000000000088.
10
Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.散发性胰腺癌的前驱病变:PanIN、IPMN 和 MCN。
Biomed Res Int. 2014;2014:474905. doi: 10.1155/2014/474905. Epub 2014 Mar 24.